• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A simple viral neuraminidase-based detection for high-throughput screening of viral hemagglutinin-host receptor specificity

tetano

Editor, Senior Moderator
Methods Mol Biol. 2014;1200:107-20. doi: 10.1007/978-1-4939-1292-6_10.
A simple viral neuraminidase-based detection for high-throughput screening of viral hemagglutinin-host receptor specificity.
Sriwilaijaroen N1, Suzuki Y.
Author information
Abstract

The correlation between precise interactions of influenza A virus hemagglutinins with host cell surface glycans having terminal sialic acids and host range specificity has provoked the development of a high-throughput viral-receptor specificity assay. Here, we describe the use of the virus itself as a specific antibody coupled to enzymes (virus with neuraminidase spikes) for determining its binding specificity to glycans, a strategy that reduces not only the cost but also the tedious steps of adding primary and secondary antibodies and washing between each step. All of the steps, including coating the glycopolymers onto microtiter plates, virus binding, and visual and quantitative detection of fluorescence products that correlate well with the amount of glycan-bound viruses, can be done within 3 h. This simple, rapid, sensitive, and reliable strategy is an ideal method for detection of high-throughput influenza virus receptor-binding preference not only for studies on viral evolution and transmission but also for viral surveillance in pandemic preparedness, leading to efficient prevention and control of the disease.

PMID:
25117229
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25117229
 
Back
Top Bottom